MX2023005909A - Formas cristalinas de 4-amino-n-[4-(metoximetil)fenil]-7-(1-metilc iclopropil)-6-(3-morfolinoprop-1-in-1-il)-7h-pirrolo[2,3-d]pirimi din-5-carboxamida, metodos de preparacion, y usos de las mismas. - Google Patents

Formas cristalinas de 4-amino-n-[4-(metoximetil)fenil]-7-(1-metilc iclopropil)-6-(3-morfolinoprop-1-in-1-il)-7h-pirrolo[2,3-d]pirimi din-5-carboxamida, metodos de preparacion, y usos de las mismas.

Info

Publication number
MX2023005909A
MX2023005909A MX2023005909A MX2023005909A MX2023005909A MX 2023005909 A MX2023005909 A MX 2023005909A MX 2023005909 A MX2023005909 A MX 2023005909A MX 2023005909 A MX2023005909 A MX 2023005909A MX 2023005909 A MX2023005909 A MX 2023005909A
Authority
MX
Mexico
Prior art keywords
methods
morpholinoprop
pyrrolo
methoxymethyl
carboxamide
Prior art date
Application number
MX2023005909A
Other languages
English (en)
Inventor
Tiziano Fumagalli
Stefano Luca Giaffreda
Enrico Modena
Gionata Frasca
Cristina Ianni
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of MX2023005909A publication Critical patent/MX2023005909A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan diversas formas cristalinas de 4-amino-N-[4(metoximetil)fenil]-7-(1-metilciclopropil)-6-(3-morfo linoprop-1-in-1-il)-7H-pirrolo[2,3-d]pirimidin-5-carboxamida, métodos de producción de las mismas, y métodos de uso de las mismas para la inhibición de RET.
MX2023005909A 2020-11-20 2021-11-18 Formas cristalinas de 4-amino-n-[4-(metoximetil)fenil]-7-(1-metilc iclopropil)-6-(3-morfolinoprop-1-in-1-il)-7h-pirrolo[2,3-d]pirimi din-5-carboxamida, metodos de preparacion, y usos de las mismas. MX2023005909A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063116191P 2020-11-20 2020-11-20
PCT/EP2021/082093 WO2022106514A1 (en) 2020-11-20 2021-11-18 Crystalline forms of 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-1-yn-1-yl)-7h-pyrrolo[2,3-d]pyrimidine-5-carboxamide, methods of preparation, and uses thereof

Publications (1)

Publication Number Publication Date
MX2023005909A true MX2023005909A (es) 2023-05-26

Family

ID=78770633

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005909A MX2023005909A (es) 2020-11-20 2021-11-18 Formas cristalinas de 4-amino-n-[4-(metoximetil)fenil]-7-(1-metilc iclopropil)-6-(3-morfolinoprop-1-in-1-il)-7h-pirrolo[2,3-d]pirimi din-5-carboxamida, metodos de preparacion, y usos de las mismas.

Country Status (13)

Country Link
US (1) US20240010653A1 (es)
EP (1) EP4247814A1 (es)
JP (1) JP2023552305A (es)
KR (1) KR20230110547A (es)
CN (1) CN116724041A (es)
AR (1) AR124092A1 (es)
AU (1) AU2021380910A1 (es)
CA (1) CA3201274A1 (es)
CL (1) CL2023001446A1 (es)
IL (1) IL302438A (es)
MX (1) MX2023005909A (es)
TW (1) TW202237608A (es)
WO (1) WO2022106514A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018016724B1 (pt) 2016-02-23 2024-02-20 Taiho Pharmaceutical Co., Ltd Composto de pirimidina condensado ou sal do mesmo, seus usos, inibidor de ret, agente antitumor e composição farmacêutica

Also Published As

Publication number Publication date
AU2021380910A1 (en) 2023-05-25
US20240010653A1 (en) 2024-01-11
CL2023001446A1 (es) 2023-12-29
KR20230110547A (ko) 2023-07-24
IL302438A (en) 2023-06-01
CA3201274A1 (en) 2022-05-27
TW202237608A (zh) 2022-10-01
CN116724041A (zh) 2023-09-08
AR124092A1 (es) 2023-02-15
JP2023552305A (ja) 2023-12-15
EP4247814A1 (en) 2023-09-27
WO2022106514A1 (en) 2022-05-27

Similar Documents

Publication Publication Date Title
AU2019231551A8 (en) Substituted 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones
NZ700583A (en) Novel 7-deazapurine nucleosides for therapeutic uses
MX370814B (es) Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
PH12016502060A1 (en) Processes for preparing jak inhibitors and related intermediate compounds
MX2019004951A (es) Proceso para la preparacion de pirazolo[1,5-a]pirimidinas y sales de estas.
MX370390B (es) Compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1, 5-a]pirimidin-3-carboxamida util como inhibidor de cinasa de ataxia telangiectasia mutada (atm) y rad3 relacionados (atr), su preparacion, diferentes formas solidas y sus derivados radiomarcados.
CR20160250A (es) Acrilamidas de pirrolo[2,3-d]piriminilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinilo
NZ604345A (en) Pyrazolo[1,5-a]pyrimidines as antiviral agents
EA201070013A1 (ru) СОЛИ ИНГИБИТОРА ЯНУС-КИНАЗЫ (R)-3-(4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
ECSP088906A (es) PIRAZOLO 1,5-a PIRIMIDINAS
PE20151249A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
GB0523012D0 (en) Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
EP4249071A3 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
MX2023004518A (es) Compuestos espiro heterocíclicos y métodos de uso.
MX2023004802A (es) Compuestos espiro heterocíclicos y métodos de uso.
MX2020013896A (es) Proceso de fabricacion e intermediarios para un compuesto de pirrolo[2,3-d]pirimidina y su uso.
NZ598144A (en) Kinase inhibitors, prodrug forms thereof and their use in therapy
EP4072548A4 (en) COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZINE-1-YL)PYRAZOLO[ 1,5-A]PYRIMIDINE ANALOGUES AS INHIBITORS BY KRAS
MX2023005909A (es) Formas cristalinas de 4-amino-n-[4-(metoximetil)fenil]-7-(1-metilc iclopropil)-6-(3-morfolinoprop-1-in-1-il)-7h-pirrolo[2,3-d]pirimi din-5-carboxamida, metodos de preparacion, y usos de las mismas.
MX2018009912A (es) Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina.
ZA202106014B (en) Solid forms of condensed pyrazines as syk inhibitors
WO2006091587A3 (en) Use of minoxidil sulfate as an anti-tumor drug
MX2019007462A (es) Formas cristalinas de un inhibidor de quinasa janus.
MX2019000159A (es) Pirrolo[2,3-d]piridazin-4-onas sustituidas y pirazolo[3,4-d]pirida zin-4-onas como inhibidores de la proteina quinasa.
EA202191541A1 (ru) ЗАМЕЩЕННЫЕ ФОСФОРОРГАНИЧЕСКИМИ ГРУППАМИ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET И ИХ ТЕРАПЕВТИЧЕСКИЕ ПРИМЕНЕНИЯ